Blood metabolite panel may help flag lung cancer risk in people who have smoked
Cell Reports Medicine describes a blood-based panel that could help identify people who have smoked and face elevated one-year lung cancer risk, potentially guiding screening.
TLDR
Cell Reports Medicine reports that a blood-based metabolite panel complements clinical risk models for lung cancer incidence and mortality. The researchers say it can identify people who have smoked and face elevated one-year lung cancer risk who would benefit from screening.
Blood metabolite panel may help flag lung cancer risk in people who have smoked
Cell Reports Medicine describes a blood-based panel that could help identify people who have smoked and face elevated one-year lung cancer risk, potentially guiding screening.
TLDR
Cell Reports Medicine reports that a blood-based metabolite panel complements clinical risk models for lung cancer incidence and mortality. The researchers say it can identify people who have smoked and face elevated one-year lung cancer risk who would benefit from screening.
